Illumina and GenoScreen Deeplex Myc-TB Combo Kit: Unleashing Precision in Infectious Disease Diagnostics

Embark on a new frontier in infectious disease diagnostics with the Illumina and GenoScreen Deeplex Myc-TB Combo Kit. This groundbreaking collaboration harnesses the power of advanced genomic technologies to revolutionize the detection and characterization of Mycobacterium tuberculosis and non-tuberculous mycobacteria. Dive into a realm where precision meets efficiency, redefining the landscape of infectious disease management.

The Illumina and GenoScreen Deeplex Myc-TB Combo Kit transcends traditional infectious disease diagnostics. It’s not merely a test; it’s a transformative solution that caters to the diverse needs of patients and communities. By providing unparalleled genomic insights, it empowers healthcare providers to make informed decisions, ushering in a new era of precision in infectious disease management.

Whether diagnosing specific mycobacterial strains or conducting predictive analyses for community-wide health, the Deeplex Myc-TB Combo Kit is your ally in the journey towards more informed and personalized infectious disease decisions. Illuminate the path to healthier communities with Illumina and GenoScreen.

  • Respiratory Samples
  • Sputum Samples
  • Culture Isolates

This versatility in sample types underscores the adaptability of the Deeplex Myc-TB Combo Kit across various clinical scenarios.

Comprehensive Mycobacterial Analysis:

The Deeplex Myc-TB Combo Kit employs state-of-the-art genomics, providing an exhaustive analysis of Mycobacterium tuberculosis and non-tuberculous mycobacteria. This depth of insight is crucial for accurate diagnosis and tailored treatment strategies.

Diagnostic Precision for Patients:

Conducted directly on patient samples, this kit serves as a diagnostic powerhouse, offering unprecedented insights into the specific mycobacterial strains at play. It sets the stage for optimal and personalized infectious disease treatment, ensuring precision and efficacy.

Predictive Analysis for Informed Decisions:

Extend the impact beyond individual diagnoses. The Deeplex Myc-TB Combo Kit empowers healthcare providers to conduct predictive analyses, shedding light on potential risks within broader communities. This foresight is invaluable for proactive healthcare planning and strategic decision-making.


Product Highlights

The Illumina and GenoScreen Deeplex® Myc-TB Combo Kit is a targeted next generation sequencing panel for the identification of Mycobacterium tuberculosis complex (MTBC) strains, mycobacterial species identification, genotyping, and prediction of drug resistance mutations of MTBC strains. Data analysis is included via a cloud-based Deeplex® software web application with results visualization. Two kit options are available based on which library prep is desired.

Identification of resistance mutations to 15 anti-tuberculosis drugs

Genotyping and spoligotyping of MTBC strains to determine lineage and sublineage of strains present in a sample

Identification of >140 mycobacterial species and detection of co-infections with distinct species

Total turnaround time less than 48 hours directly from sputum with no need to perform culture